Acta Scientific Gastrointestinal Disorders (ISSN: 2582-1091)

Review Article Volume 3 Issue 3

Pseudomembranous Colitis: Current Scenario in Paediatric Practice

Suraj Gupte*

Professor and Head (Emeritus), Postgraduate Department of Paediatrics, Mamata Medical College, Khammam, India

*Corresponding Author: Suraj Gupte, Professor and Head (Emeritus), Postgraduate Department of Paediatrics, Mamata Medical College, Khammam, India. E-mail:

Received: December 12, 2019; Published: February 11, 2020



  The paper aims at providing a state-of-the-art review of the English medical literature punctuated by our own experience spread over 2 decades on pseudomembranous colitis (PMC) as a result of proliferation of the pathogen, Clostridium difficile, in the gut in children on antibiotics.

   Though antibiotic-associated colitis from C. difficile (the classical form) accounts for most cases of pseudomembranous colitis (inflammatory plaques on colonic mucosa) in practice, non-C. difficile PMC is also known. Over the recent decades, incidence of classical PMC has been showing increasing incidence because of massive overuse, nay abuse, of antibiotics.

   Usual manifestations include diarrhoea (often “bloody”), abdominal discomfort/pain/tenderness, fever, diarrhoeal dehydration and generalised weakness Confirmation of the clinical diagnosis is by demonstration of C. difficile in stools, lower endoscopy, procto-sigmoidoscopy, and imaging studies.

   Treatment comprises withdrawal of the offending antibiotic, drug therapy with metronidazole (or its prototypes), vancomycin, or fidaxomicin, or their varying combinations. In severe and recurrent cases, faecal transplantation may prove life-saving.

   Prophylaxis is in the form of hygienic measures and rational use of antibiotics and its propagation via antibiotic stewardship program. An cost-effective vaccine remains to be available for clinical use.

Keywords: Antibiotic-Associated Diarrhea; Bloody Diarrhoea; Clostridium difficile; Diarrhoea; Fidaxomicin Metronidazole; Pseudomembranous Colitis; Vaccine; Vancomycin



  1. Henry R. “Antibiotic-associated colitis and pseudomebranous colitis: New trends”. Third Trans-Asia Conference on Disorders of Gut and Liver, Hong Kong (2017). 
  2. Tang DM., et al. “Pseudomembranous colitis: Not always Clostridium difficile”. Cleveland Clinic Journal of Medicine 83 (2016): 361-366.
  3. Gupte N and Gupte S. “Antibiotic-associated diarrhea: Pharmacotherapy and preventive aspects in children”. Journal of Gastroenterology and Hepatology 2 (2017): 600-605. 
  4. Gupte S. “Differential Diagnosis in Pediatrics”. 6th edn. New Delhi: Jaypee (2020). 
  5. Gupte S. “Instructive Case Studies in Pediatrics”. 5th edn. New Delhi: Jaypee (2013). 
  6. Haran JP., et al. “Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: Risk of administering IV antibiotics”. American Journal of Emergency Medicine 32 (2014): 1195-1199. 
  7. World Health Organization. Diarrheal Disease. Geneva: WHO (2000). 
  8. Gupte S and Pal M. “The problem of antibiotic-related diarrhea (colitis) in north Indian children”. Eur Bull Gastroenterol 7 (1997): 123-129. 
  9. Wisham J., et al. “Frequency of antibiotic associated diarrhea in 2462 antibiotic treated hospitalized patients: A prospective study”. Journal of Antimicrobe and Chemotherapy 47 (2000): 43-50. 
  10. Ferguson AW. “Antibiotic-related diarrhea/colitis in pediatric practice”. Euro-Med Bulletin 7 (2001): 123-129. 
  11. Smith E., et al. “Antibiotic-related diarrheal illness”. Euro-Med Bulletin 7 (2001): 34-39. 
  12. Robert AS. “Letter to the Editor: Antibiotic-related diarrheas”. Euro-Med Bulletin 7 (2001): 99-100.
  13. Sutana Q., et al. “Diagnosis of Clostridium difficile antibiotic-associated culture versus toxin assay”. Journal of the Pakistan Medical Association 50 (2000): 246- 249.
  14. Gorenek L., et al. “The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea”. Hepatogastroenterology 46 (1999): 343- 348. 
  15. Gupte S. “Antibiotic-associated diarrhea in children”. In: Thapa BR (ed): Recent Advances in Pediatric Clinical Gastroenterology. Chandigarh: Relume Printec (2001): 42-47. 
  16. Cleary RK. “Clostridium difficile-associated diarrhea and colitis: Clinical manifestations, diagnosis and treatment”. Diseases of the Colon and Rectum 41 (1998): 1439-1445. 
  17. Bergogne-Berezin E. “Treatment and prevention of antibiotic-associated diarrhea”. International Journal of Antimicrobe Agents 16 (2001): 521-526. 
  18. Gupte S and Pal M. “Perspectives in antibiotic-associated diarrhea in pediatric practice (Abstract of the invited lecture)”. Proceedings of the International Conference on Paediatric Diarrhoeas, Hong Kong (1999).
  19. Suvarna J. “Antibiotics and diarrhea). In: Gupte S, Horvath K (eds): Pediatric Gastroenterology, Hepatology and Nutrition. New Delhi: Peepee (2009): 210-219. 
  20. Gopalan S. “Prebiotics and probiotics: A possible beneficial role in diarrhoea”. In: Thapa BR (ed): Recent Advances in Pediatric Clinical Gastroenterology. Chandigarh: Relume Printec (2001): 48-54. 
  21. Clorba MA. “A gastroenterologist’s guide to probiotics”. Clinical Gastroenterology and Hepatology 10 (2012): 960-968.
  22. Raza S., et al. “Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan”. Pediatric Infection Disease 14 (1995): 107-111. 
  23. Saavedra J. “Probiotics and infectious diarrhea”. American Journal of Gastroenterology 95 (2000): S16-S18. 
  24. Gibsoin GR and Roberfroid MB. “Dietary modification of the human colonic microbiota: Introducing the concept of probiotics”. Journal of Nutrition 125 (1995): 1401-1412. 
  25. Salminen S., et al. “Clinical uses of probiotics for stabilizing the gut muosal barrier: Successful strains and future”. Asia Pacific Journal of Clinical Nutrition 5(1996): 53-56.
  26. Sougioultzis S., et al. “Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea”. Gastroenterology 128 (2005): 764-770. 
  27. Ghose C. “Clostridium difficile infection in twenty-first century”. Emerging Microbes and Infections 2 (2013): e62.
  28. Riley TV., et al. “Status of vaccine research and development for Clostridium difficile”. Vaccine 28 (2019):7300-7306.


Citation: Suraj Gupte. “Pseudomembranous Colitis: Current Scenario in Paediatric Practice”.Acta Scientific Gastrointestinal Disorders 3.3 (2020): 09-13.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor0.622

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US